|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 239/96 | |
| C07D 401/06 | |||
| A61K 31/517 | |||
| A61P 9/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 2709990 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12765230.3 |
| Date of filing the European patent application | 2012-03-31 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2012/073362 |
| Date | 2012-03-31 |
| (87) | Number | WO 2012/130166 |
| Date | 2012-10-04 |
| (30) | Number | Date | Country code |
| 201110082475 | 2011-04-01 | CN | |
| PCT/CN2011/0770 | 2011-07-11 | WO |
| (72) |
CAI, Sui Xiong, CN
TIAN, Ye Edward, CN
DONG, Haijun, CN
XU, Qingbing, CN
WU, Lizhen, CN
LIU, Lijun, CN
JIANG, Yangzhen, CN
BAO, Qingli, CN
WANG, Guoxiang, CN
YIN, Feng, CN
GU, Chengyun, CN
HU, Xiuhua, CN
WANG, Xiaozhu, CN
KANG, Sishun, CN
CHEN, Shengzhi, CN
|
| (73) |
Impact Therapeutics, Inc.,
Floor 9 10 Xinghuo Road Nanjing, Jiangsu 210061,
CN
|
| (54) | 1-((3-((1-Piperazinyl)carbonyl)phenyl)methyl)-2,4(1H,3H)-quinazolinedione derivatives as PARP inhibitors for treating cancer |
| 1-((3-((1-Piperazinyl)carbonyl)phenyl)methyl)-2,4(1H,3H)-quinazolinedione derivatives as PARP inhibitors for treating cancer |